Clinical Trial Update: A Dose-Finding Study of MM120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding trial of MM120 (LSD D-tartrate) for generalized anxiety disorder has completed enrollment with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• MM120

Snippet

Sponsor: Definium Therapeutics US, Inc. | Conditions: Anxiety Generalized | Phase 2 | Status: COMPLETED | Results posted: 2025-03-20